65,437 trials
Attention Deficit Hyperactivity Disorder
Primary: Total ADHD Symptom Score From Vanderbilt ADHD Parent Rating Scale — 25.94; 28.28 units on a scale — p=.35
Ebola Virus
Primary: Serious Adverse Events. — 6; 6; 8 Participants — p=0.68
Testicular Hypogonadism
Primary: Responder Rate - the Percentage of Subjects Whose Minimum Concentration Observed (Cmin) and Average Steady State Concentration (Cave) of Serum Testosterone Levels Were…
Venous Thromboembolism · Postpartum
Primary: Feasibility of Recruitment and Trial Operations. — 0.9; 0.9 participants per site per month
Candidiasis, Invasive · Candidemia · Mycoses
Primary: Percentage of Participants With Overall Response of Success at the End of Intravenous Therapy (EOIV) as Determined by the Data Review Committee (DRC) Based on the…
Ischemic Optic Neuropathy
Primary: Efficacy in Detecting Subtle Intraoperative VEP Changes Using SightSaver Visual Stimulator During Spine Prone Surgeries Under Balanced General Anesthesia Versus TIVA…
Inflammatory Responses
Primary: Change in C Reactive Protein (CRP) — 17.2; 17.1 mg/L
Smoking Cessation
Primary: Expired-air CO Verified Point-prevalence Abstinence — 44; 42 participants
Caffeine
Primary: Intubation — 3; 7 participants
Acute Coronary Syndrome · Heart Failure
Primary: Number of Serious Medication Errors as Determined by Interview and Medical Chart Review — 0.95; 0.87 serious medication errors
Peritoneal Carcinomatosis
Primary: The Grouped Miller and Payne (MP) System for Pathological Response: G1 (Minimal Changes and < 30% Cells Tumour Reduction That Includes MP G1-G2), G3 (Microscopic Foci…
Multiple Myeloma
Primary: Progression-Free Survival (PFS) — 22.1; 22.3 months — p=0.1590
Bipolar Depression
Primary: Weight in Kilograms at Baseline, Weeks 1, 4, 6, and 8 — 76.0; 76.1; 77.4; 77.6 kilograms
Progeria · Hutchinson-Gilford Syndrome
Primary: The Primary Objective of This Study is to Evaluate the Feasibility of Administering Intravenous Zoledronic Acid, Oral Pravastatin and Oral Lonafarnib, to Patients With…
Breast Cancer
Primary: Cardiac Toxicity of Weekly Taxol Given With Weekly Herceptin When Delivered Immediately Following Four Cycles of Standard Dose AC. — 1; 8; 3; 11 Participants